For more about how Chevron invests in public health, visit http://www.chevron.com Chevron partnered with the Angolan government and Baylor College of Medicine International Pediatric AIDS Initiative at Texas Children's Hospital to establish Angola's first sickle cell disease testing and treatment program in March 2011. Chevron is supporting the Angola Sickle Cell Initiative with $4 million over four years. Here is the original post: Chevron Fights Sickle Cell in Angola - Video … Continue reading →

Major General James Gilman, Commanding General of the US Army Medical Research and Material Command, outlined the US army's extensive research efforts in stem cell technologies and their mission to discover, develop and translate regenerative medicine. He spoke about the military's desire to partner with academia and industry to generate effective treatments for volume, bone, muscle and tissue injuries and about spinal cord regeneration as the military's biggest challenge and hope. Read more here: 2011 Summit: Harnessing Regenerative Medicine for US Service-members, Major General James K. Gilman - Video … Continue reading →

Arthritis Treatment Complications of stem cell procedures - Tip 5 Read this article: Arthritis Treatment Complications of stem cell procedures - Tip 5 - Video … Continue reading →

Andy Grove, PhD and Former CEO of Intel Corporation, dared to suggest that translational medicine will be a "bridge to nowhere" if the way we handle the development of new drugs does not undergo a serious transformation. He proposed a radical rethinking of our whole regulatory and IP system, encouraging all members of the stem cell community to stimulate action and push for change. Read more from the original source: 2011 Summit: Translational Medicine: Key to Progress or Bridge to Nowhere?, Andrew S. Grove, PhD - Video … Continue reading →

Alan Trounson, PhD and President of the California Institute for Regenerative Medicine, offered a positive and forward looking keynote address. Trounson provided an update on CIRM's translational roadmap to regenerative medicine and outlined their accomplishments with over $300 million in funding for human embryonic stem cell research, adult stem cells, cancer stem cells, reprogrammed stem cells and endogenous stem cells for multiple treatments. He spoke about progress in these areas of research emphasizing their promise and relating how close many treatments are to becoming a reality. Follow this link: 2011 Summit: Keynote Address, CIRM's Translational Roadmap to Stem Cell Cures, Alan Trounson, PhD - Video … Continue reading →

Alan Trounson, PhD and President of the California Institute for Regenerative Medicine, offered a positive and forward looking keynote address. Trounson provided an update on CIRM's translational roadmap to regenerative medicine and outlined their accomplishments with over $300 million in funding for human embryonic stem cell research, adult stem cells, cancer stem cells, reprogrammed stem cells and endogenous stem cells for multiple treatments. He spoke about progress in these areas of research emphasizing their promise and relating how close many treatments are to becoming a reality. Follow this link: 2011 Summit: Keynote Address, CIRM's Translational Roadmap to Stem Cell Cures, Alan Trounson, PhD - Video … Continue reading →

Rudolf Jaenisch, MD (MIT) and recently named winner of the National Medal of Science, discussed the key issues facing the field of highly pluripotent stem cells including ES cells and iPS cells. He outlined the main conditions that affect the quality of stem cells including genetics background, culture, isolation and environmental conditions, adding that subtle phenotypes may be disease relevant. See more here: 2011 Summit: Stem Cells, Reprogramming and Personalized Medicine, Rudolf Jaenisch, MD - Video … Continue reading →